SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-299958
Filing Date
2019-11-25
Accepted
2019-11-25 16:47:57
Documents
2
Group Members
JOSHUA RICHARDSONJULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS III, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D d791325dsc13d.htm SC 13D 119642
2 EX-99.1 d791325dex991.htm EX-99.1 5580
  Complete submission text file 0001193125-19-299958.txt   126957
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89009 | Film No.: 191246734
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025 650-845-5700
Longitude Capital Partners III, LLC (Filed by) CIK: 0001713663 (see all company filings)

IRS No.: 811668051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D